176 related articles for article (PubMed ID: 18437502)
1. Intraarterial chemotherapy for extremity osteosarcoma and MFH in adults.
Hugate RR; Wilkins RM; Kelly CM; Madsen W; Hinshaw I; Camozzi AB
Clin Orthop Relat Res; 2008 Jun; 466(6):1292-301. PubMed ID: 18437502
[TBL] [Abstract][Full Text] [Related]
2. The value of serial arteriography in osteosarcoma: delivery of chemotherapy, determination of therapy duration, and prediction of necrosis.
Cullen JW; Jamroz BA; Stevens SL; Madsen W; Hinshaw I; Wilkins RM; Cullen P; Camozzi AB; Fink K; Peck SD; Kelly CM
J Vasc Interv Radiol; 2005 Aug; 16(8):1107-19. PubMed ID: 16105923
[TBL] [Abstract][Full Text] [Related]
3. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan.
Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH
Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimen.
Bacci G; Ferrari S; Bertoni F; Mercuri M; Forni C; Sottili S; Gasbarrini A; Tienghi A; Cesari M; Campanacci M
J Chemother; 1997 Aug; 9(4):293-9. PubMed ID: 9269611
[TBL] [Abstract][Full Text] [Related]
5. Improved survival in primary nonmetastatic pediatric osteosarcoma of the extremity.
Wilkins RM; Cullen JW; Camozzi AB; Jamroz BA; Odom L
Clin Orthop Relat Res; 2005 Sep; 438():128-36. PubMed ID: 16131881
[TBL] [Abstract][Full Text] [Related]
6. Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity.
Wilkins RM; Cullen JW; Odom L; Jamroz BA; Cullen PM; Fink K; Peck SD; Stevens SL; Kelly CM; Camozzi AB
Ann Surg Oncol; 2003 Jun; 10(5):498-507. PubMed ID: 12794015
[TBL] [Abstract][Full Text] [Related]
7. Nonmetastatic osteosarcoma of the extremity: results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intraarterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor response.
Ferrari S; Mercuri M; Picci P; Bertoni F; Brach del Prever A; Tienghi A; Mancini A; Longhi A; Rimondini S; Donati D; Manfrini M; Ruggieri P; Biagini R; Bacci G
Tumori; 1999; 85(6):458-64. PubMed ID: 10774566
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone and in osteosarcoma located in the extremities: analogies and differences between the two tumors.
Picci P; Bacci G; Ferrari S; Mercuri M
Ann Oncol; 1997 Nov; 8(11):1107-15. PubMed ID: 9426330
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European Osteosarcoma Intergroup study.
Bramwell VH; Steward WP; Nooij M; Whelan J; Craft AW; Grimer RJ; Taminau AH; Cannon SR; Malcolm AJ; Hogendoorn PC; Uscinska B; Kirkpatrick AL; Machin D; Van Glabbeke MM
J Clin Oncol; 1999 Oct; 17(10):3260-9. PubMed ID: 10506628
[TBL] [Abstract][Full Text] [Related]
10. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.
Bacci G; Picci P; Ferrari S; Ruggieri P; Casadei R; Tienghi A; Brach del Prever A; Gherlinzoni F; Mercuri M; Monti C
Cancer; 1993 Dec; 72(11):3227-38. PubMed ID: 8242546
[TBL] [Abstract][Full Text] [Related]
11. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
[TBL] [Abstract][Full Text] [Related]
12. [Neoadjuvant chemotherapy of osteosarcoma. Preliminary results of the cooperative COSS-86 osteosarcoma study].
Bieling P; Bielack S; Delling G; Jürgens H; Kotz R; Dose C; Astheimer H; Exner G; Gadner H; Graf N
Klin Padiatr; 1991; 203(4):220-30. PubMed ID: 1942929
[TBL] [Abstract][Full Text] [Related]
13. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin.
Bacci G; Picci P; Ruggieri P; Mercuri M; Avella M; Capanna R; Brach Del Prever A; Mancini A; Gherlinzoni F; Padovani G
Cancer; 1990 Jun; 65(11):2539-53. PubMed ID: 2337871
[TBL] [Abstract][Full Text] [Related]
14. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol.
Bacci G; Ferrari S; Longhi A; Forni C; Bertoni F; Fabbri N; Zavatta M; Versari M
J Chemother; 2001 Feb; 13(1):93-9. PubMed ID: 11233808
[TBL] [Abstract][Full Text] [Related]
16. [Intra-arterial neoadjuvant chemotherapy of sarcoma of the extremities].
Graziani G; Priori T; Fiorentini G; Molinari M; Tienghi A
Radiol Med; 1990 Oct; 80(4):474-6. PubMed ID: 2173854
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs.
Fuchs N; Bielack SS; Epler D; Bieling P; Delling G; Körholz D; Graf N; Heise U; Jürgens H; Kotz R; Salzer-Kuntschik M; Weinel P; Werner M; Winkler K
Ann Oncol; 1998 Aug; 9(8):893-9. PubMed ID: 9789613
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study.
Nooij MA; Whelan J; Bramwell VH; Taminiau AT; Cannon S; Hogendoorn PC; Pringle J; Uscinska BM; Weeden S; Kirkpatrick A; Glabbeke Mv; Craft AW;
Eur J Cancer; 2005 Jan; 41(2):225-30. PubMed ID: 15661546
[TBL] [Abstract][Full Text] [Related]
19. Intraarterial cisplatinum and intravenous adriamycin for primary hypervascular bone tumor: experience of seven cases.
Huang CH; Wang JW; Lee TY
J Formos Med Assoc; 1993 Dec; 92(12):1084-9. PubMed ID: 7911358
[TBL] [Abstract][Full Text] [Related]
20. MFH of bone and osteosarcoma show similar survival and chemosensitivity.
Jeon DG; Song WS; Kong CB; Kim JR; Lee SY
Clin Orthop Relat Res; 2011 Feb; 469(2):584-90. PubMed ID: 20559764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
